Licensing and

Business Development

Hexaphoenix offer branded generic products in different development stages. By developing and manufacturing the majority of our products to make it readily available eCTD dossiers Licensing with supply from our European R & D Facilities.

We offer the products which are developed and manufactured to UK medicines and Healthcare Regulatory Agency (MHRA) and EUGMP standards. All of molecules have Marketing Authorizations issued by the MHRA and EU Authorities with Certificate of Pharmaceutical Product (CPP) available.

WE ARE INTERESTED:

  • LICENSING-IN: Licensing–In of dossiers for our own products portfolio.
  • DISTRIBUTION AGREEMENT: Distribution agreement for expansion of products pipeline in the worldwide.

WE OFFER:

  • LICENSING-OUT: Licensing-Out for developed dossier in e CTD, CTD and ACTD format.
  • CONTRACT MANUFACTURING: Manufacturing by contract in a EUGMP and WHOGMP environment.
  • PRODUCT DEVELOPMENT: Product Development by contract or through partnership.

– List of EU and UK products

For more detailed information on our products please contact us!

Strength: 100mg /200mg

Dosage: Capsules

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 75mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 250mg /500mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 1.25mg /2.5mg/3.75mg/5mg/7.5mg/10mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10mg/20mg/30mg/40mg/60mg

Dosage: Capsules

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD / ACTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 30mg/60mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 40/160mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 500mg/750mg/1000mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10mg/25mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10/25mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: Prochlorperazine |  Tablet |  5mg
Prochlorperazine (OTC) | Buccal Tablet | 3mg
Prochlorperazine (Prescription Only) | Buccal Tablet | 3mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 250 mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10 mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10 mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 7.5mg/5ml, 30mg/5ml

Dosage: Syrup

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 5/10/20/25mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 375mg

Dosage: Capsules

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD / ACTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 250mg/5ml

Dosage: Syrup

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 800mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 5mg / 7.5mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 5mg/5ml

Dosage: Syrup

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 30 mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 50/100mg

Dosage: Capsules

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 12.5/25/50/100mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 0.5mg / 0.75mg / 1.0mg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 2mg + 125mg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 2mg + 125mg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 2mg

Dosage: ODT (Lingual) Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 8mg /16mg / 24mg /48mg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 0.5mg / ml

Dosage: Oral Solution

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 500 mg / 1000mg

Dosage: Granules in Sachet

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 1mg/5mg/10mg

Dosage: Film Coated Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 62.5 mcg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 5 IU and 10 IU

Dosage: Injection

Approved Authority: WHO Prequalified and From EUGMP Approved Plant

Dossiers Available: Ready CTD

Bioequivalence (BE/BA) study: Not Required for Injection

Market Availability: Not available for Ghana, Tanzania, Vietnam, Sri Lanka.